From: The prevalence of estrogen receptor-negative breast cancer in Ethiopia
Parameter | ER available: N (column%) | ER not available: N (column%) |
---|---|---|
Total population n = 1213 | 352 (100.0) | 861 (100.0) |
Place of origin | ||
Addis Ababa | 183 (52.0) | 405 (47.0) |
Non-Addis Ababa | 140 (39.8) | 375 (43.6) |
unknown | 29 (8.2) | 81 (9.4) |
Age (years) | ||
<30 | 56 (15.9) | 106 (12.3) |
30–39 | 114 (32.4) | 331 (38.4) |
40–49 | 83 (23.6) | 231 (26.8) |
50–59 | 53 (15.1) | 139 (16.1) |
≥60 | 46 (13.1) | 54 (6.3) |
Menopausal status | ||
Premenopausal | 145 (41.2) | 345 (40.1) |
Postmenopausal | 155 (44.0) | 374 (43.4) |
Unknown status | 52 (14.8) | 142 (16.5) |
Stage (UICC) | ||
1 and 2 | 35 (9.0) | 153 (17.8) |
3 | 168 (47.7) | 288 (33.4) |
4 | 71 (20.2) | 72 (8.4) |
Unknown | 78 (22.2) | 348 (40.4) |
Distant Metastasis | ||
No (M0) | 236 (67.0) | 666 (77.4) |
Yes (M1) | 116 (33.0) | 195 (22.6) |
Histology | ||
Ductal | 265 (75.3) | 681 (79.1) |
Lobular | 20 (5.7) | 39 (4.5) |
other/unspecified | 67 (19.0) | 141 (16.4) |
Patho-specimen for diagnosis | ||
FNAC+ | 127 (36.1) | 27 (3.1) |
Tumour specimen | 193 (54.8) | 659 (77.0) |
unknown | 32 (9.1) | 174 (20.2) |
Basis of hormone receptor diagnosis | ||
Primary operation | 174 (49.4) | Not applicable |
Recurrence | 106 (30.1) | |
unknown | 72 (20.5) |